Security crackdown uncovers 36 crimes and detains 40 suspects
Reports have indicated that the French company Sanofi expects its COVID-19 vaccine sales to reach approximately 24 billion euros by 2026, driven by ongoing demand for the vaccine and expanded usage in global markets. The company plans to increase production and improve the vaccine's effectiveness against new variants, with expectations that this will contribute to boosting its profits in the coming years.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)